Sign in
4

Changes in Ownership

MBX Biosciences, Inc. Filed Acc 0000950170-25-014499

Options or other derivatives

  • Chief Medical Officer acquired 90,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Azoulay Salomon Chief Medical Officer 2025-02-03 Grant or award · Stock Option (Right to Buy) +90,000 90,000 D
Loading xslF345X05/ownership.xml…